RSS Feed

Latest news

Plan, learn and organise with MIMS Learning

Plan, learn and organise with MIMS Learning

MIMS Learning, our new educational website, is now...

NICE approves vedolizumab for Crohn's disease

NICE approves vedolizumab for Crohn's disease

The integrin inhibitor vedolizumab (Entyvio) has been...

Shingles vaccination eligibility updated for 2015

Shingles vaccination eligibility updated for 2015

The immunisation programme, now in its third year,...

Eloine: new low-dose combined oral contraceptive

Eloine: new low-dose combined oral contraceptive

Bayer has launched Eloine, a new combined oral contraceptive...

Study highlights inappropriate prescribing in patients with learning disabilities

Study highlights inappropriate prescribing in patients with learning disabilities

One in six adults with learning disabilities is being...


New and deleted products

Promo Image

New Products

Products added to MIMS.

Promo Image

Deleted Products

Products removed from MIMS.


Most popular

Switching and Withdrawing Antidepressants

Quick-reference guide to switching and withdrawing...

H.pylori: Eradication Regimens (NICE)

Summary of NICE guidance for treatment of Helicobacter...

Cystitis

Vaginal Infections

Summary of Antibiotic Treatments in Adults

Dose regimens for common bacterial infections.


Promo Image

Anti-Anginal Preparations

A comparison table of anti-anginal formulations grouped by class.

Promo Image

Management of COPD

At-a-glance summary of NICE guidance for COPD treatment.


Patient fact sheets

Browse the MIMS patient fact sheet library and find printable patient information on topics from acne to yellow fever.

Glaucoma

Parkinson's Disease


Manufacturers

Manufacturers

Contact details and drug listings for manufacturers in MIMS


New products coming soon to MIMS

Check back soon to find MIMS listings for the following new drugs:

Abasaglar (insulin glargine)

Akynzeo (netupitant/palonosetron)

Catephen (Camellia sinensis extract)

Moventig (naloxegol)

ODM5 (sodium chloride/sodium hyaluronate)

Ofev (nintedanib)

Repatha (evolocumab)


Latest from MIMS Dermatology

Infliximab biosimilar for psoriasis

Remsima (infliximab), an anti-inflammatory biologic...

Static mattresses and pressure ulcers

The American College of Physicians has published two...

Treatment for urticaria in Scotland

The Scottish Medicines Consortium has recommended the...


MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.




Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.

This site is intended for healthcare professionals.